PLCO Publications
Here you can browse the complete list of publications for PLCO
| Title | PubMed | Authors | Journal | Year | Studies |
|---|---|---|---|---|---|
| A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and Prostate Cancer Cohort Consortium. | 29114882 | Barrdahl M, Canzian F, Gaudet MM, Gapstur SM, Trichopoulou A, Tsilidis K, van Gils CH, Borgquist S, Weiderpass E, Khaw KT, Giles GG, Milne RL, Le Marchand L, Haiman C, Lindström S, Kraft P, Hunter DJ, Ziegler R, Chanock SJ, Yang XR, Buring JE, Lee I… | Int. J. Cancer | 2018 | PLCO |
| Biology and Clinical Implications of the 19q13 Aggressive Prostate Cancer Susceptibility Locus. | 30033361 | Gao P, Xia JH, Sipeky C, Dong XM, Zhang Q, Yang Y, Zhang P, Cruz SP, Zhang K, Zhu J, Lee HM, Suleman S, Giannareas N, Liu S, PRACTICAL Consortium, Tammela TLJ, Auvinen A, Wang X, Huang Q, Wang L, Manninen A, Vaarala MH, Wang L, Schleutker J, Wei GH | Cell | 2018 | PLCO |
| AA9int: SNP interaction pattern search using non-hierarchical additive model set. | 29878078 | Lin HY, Huang PY, Chen DT, Tung HY, Sellers TA, Pow-Sang JM, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Hamdy F, Neal DE, Pashayan N, Kh… | Bioinformatics | 2018 | PLCO |
| Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium. | 29438364 | Lophatananon A, Stewart-Brown S, Kote-Jarai Z, Al Olama AA, Garcia SB, Neal DE, Hamdy FC, Donovan JL, Giles GG, Fitzgerald LM, Southey MC, Pharoah P, Pashayan N, Gronberg H, Wiklund F, Aly M, Stanford JL, Brenner H, Dieffenbach AK, Arndt V, Park JY,… | Br. J. Cancer | 2018 | PLCO |
| Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. | 29321194 | Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Garcia SB, Muir K, Grönberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, … | BMJ | 2018 | PLCO |
| Oral Alpha, Beta, and Gamma HPV Types and Risk of Incident Esophageal Cancer. | 30087123 | Agalliu I, Chen Z, Wang T, Hayes RB, Freedman ND, Gapstur SM, Burk RD | Cancer Epidemiol. Biomarkers Prev. | 2018 | PLCO |
| Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. | 30157224 | Smith A, Mullooly M, Murphy L, Barron TI, Bennett K | PLoS ONE | 2018 | PLCO |
| The relationship between diabetes, prostate-specific antigen screening tests, and prostate cancer. | 30094676 | Miller EA, Pinsky PF, Pierre-Victor D | Cancer Causes Control | 2018 | PLCO |
| Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer. | 29978465 | Xu Y, Liu H, Liu S, Wang Y, Xie J, Stinchcombe TE, Su L, Zhang R, Christiani DC, Li W, Wei Q | Int. J. Cancer | 2018 | PLCO |
| Number of Adenomas Removed and Colorectal Cancers Prevented in Randomized Trials of Flexible Sigmoidoscopy Screening. | 29935150 | Pinsky PF, Loberg M, Senore C, Wooldrage K, Atkin W, Bretthauer M, Cross AJ, Hoff G, Holme O, Kalager M, Segnan N, Schoen RE | Gastroenterology | 2018 | PLCO |
| Association of Colonoscopy Adenoma Findings With Long-term Colorectal Cancer Incidence. | 29800214 | Click B, Pinsky PF, Hickey T, Doroudi M, Schoen RE | JAMA | 2018 | PLCO |
| Body mass index (BMI) trajectories and risk of colorectal cancer in the PLCO cohort. | 29872147 | Zheng R, Du M, Zhang B, Xin J, Chu H, Ni M, Zhang Z, Gu D, Wang M | Br. J. Cancer | 2018 | PLCO |
| Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia. | 30305637 | McMaster ML, Berndt SI, Zhang J, Slager SL, Li SA, Vajdic CM, Smedby KE, Yan H, Birmann BM, Brown EE, Smith A, Kleinstern G, Fansler MM, Mayr C, Zhu B, Chung CC, Park JH, Burdette L, Hicks BD, Hutchinson A, Teras LR, Adami HO, Bracci PM, McKay J, Mo… | Nat Commun | 2018 | PLCO |
| Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: long-term follow-up of the randomised US PLCO cancer screening trial. | 30502933 | Miller EA, Pinsky PF, Schoen RE, Prorok PC, Church TR | Lancet Gastroenterol Hepatol | 2018 | PLCO |
| Concentrated sugars and incidence of prostate cancer in a prospective cohort. | 30047347 | Miles FL, Neuhouser ML, Zhang ZF | Br. J. Nutr. | 2018 | PLCO |
| Modifiable risk factors to reduce renal cell carcinoma incidence: Insight from the PLCO trial. | 29779672 | Gelfond J, Al-Bayati O, Kabra A, Iffrig K, Kaushik D, Liss MA | Urol. Oncol. | 2018 | PLCO |
| Extended follow-up for prostate cancer incidence and mortality among participants in the Prostate, Lung, Colorectal and Ovarian randomized cancer screening trial. | 30288918 | Pinsky PF, Miller E, Prorok P, Grubb R, Crawford ED, Andriole G | BJU Int. | 2018 | PLCO |
| Association of Nonadherence to Cancer Screening Examinations With Mortality From Unrelated Causes: A Secondary Analysis of the PLCO Cancer Screening Trial. | 30592477 | Pierre-Victor D, Pinsky PF | JAMA Intern Med | 2018 | PLCO |
| Prediagnostic circulating markers of inflammation and risk of oesophageal adenocarcinoma: a study within the National Cancer Institute Cohort Consortium. | 30121626 | Cook MB, Barnett MJ, Bock CH, Cross AJ, Goodman PJ, Goodman GE, Haiman CA, Khaw KT, McCullough ML, Newton CC, Boutron-Ruault MC, Lund E, Rutegård M, Thornquist MD, Spriggs M, Giffen C, Freedman ND, Kemp T, Kroenke CH, Le Marchand L, Park JY, Simon M… | Gut | 2018 | PLCO |
| A Metabolomics Analysis of Body Mass Index and Postmenopausal Breast Cancer Risk. | 29325144 | Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews CE, Ziegler RG | J. Natl. Cancer Inst. | 2018 | PLCO |